Avonex interferon beta-1a: Phase IV data

Biogen Idec released 10-year data from the open-label CHAMPIONS study. In 155 evaluable patients, treatment with Avonex immediately upon diagnosis of a clinically isolated syndrome (CIS) in high-risk ...